The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
Clinical trial NCT05369364 · UNKNOWN
Trial details
- NCT number
- NCT05369364
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2025-12-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.